ArticleMolecular oncology2021

Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.

Sadiya Parveen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.